Monika Zaborek

Mrs. Monika Zaborek

Department of Clinical Immunology and Immunotherapy, Medical University of Lublin
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 November 2020 in Cells
Verified
Journal Article
Open access
PDF file
EGEwelina Grywalska
Ewelina Grywalska
MZMonika Zaborek
Monika Zaborek
JŁJakub Łyczba
Jakub Łyczba
Rafał HrynkiewiczRafał Hrynkiewicz
Rafał Hrynkiewicz
DBDominika Bębnowska
Dominika Bębnowska
Paulina Niedźwiedzka-RystwejPaulina Niedźwiedzka-Rystwej
Paulina Niedźwiedzka-Rystwej
Secondary immunodeficiency is observed in all patients with chronic lymphocytic leukemia (CLL) in varying degrees. The aim of the study was to review the available literature data on patients with CLL, with particular regard to the pathogenesis of the disease and the impact of humoral immunity deficiency on the clinical and therapeutic approach. A systematic literature review was carried out by two independent authors who searched PubMed databases for studies published up to January 2020. Additionally, Google Scholar was used to evaluate search results and support manual research. The search resulted in 240 articles eligible for analysis. After all criteria and filters were applied, 22 studies were finally applied to the analysis. The data analysis showed that the clinical heterogeneity of CLL patients correlates with the diversity of molecular abnormalities determining the clinical picture of the disease, the analysis of which enables setting therapeutic targets. Additionally, in improving the therapeutic method, it is worth introducing supportive therapies with the use of vaccines, antibiotics and/or immunoglobins. Moreover, humoral immunodeficiency in CLL has a strong influence on the risk of infection in patients for whom infections are a major cause of morbidity and mortality.

27 June 2024 in Applied Sciences
Verified
Journal Article
Open access
PDF file
AGAgata Ginszt
Agata Ginszt
Grzegorz ZielińskiGrzegorz Zieliński
Grzegorz Zieliński
ABAleksandra Byś
Aleksandra Byś
ESEstera Stachyra
Estera Stachyra
MZMonika Zaborek
Monika Zaborek
Michał GinsztMichał Ginszt
Michał Ginszt
Based on previous research studies and systematic reviews, success in sport climbing seems to be determined by variables such as strength, power, or endurance. However, besides strength-endurance parameters, several other factors may influence the performance of sports climbing. Moreover, there is a lack of research assessing differences in body composition and anthropometric parameters between lead climbing and bouldering—the two most common sport climbing subdisciplines. The presented research analyzed the connection between body mass, body height, body mass index, and the best result in sport climbing among male lead climbers and boulderers. Additionally, we investigated differences in starting climbing age and climbing experience in both climbing subdisciplines. We analyzed 422 male sport climbers’ profiles in two categories: “Route Ranking: Top-10 climbs last 12 months” for lead climbers and “Boulder Ranking: Top-10 climbs last 12 months” for boulderers based on the 8a.nu world ranking website. The results showed that the “Elite” and “Higher Elite” lead climbers had lower body mass and lower body height. These differences were also observed between “Elite” and “Higher Elite” lead climbers. The “Higher Elite” group started climbing at a younger age and had a more extended period to achieve the most challenging route than “Elite” climbers in both subdisciplines. Our results suggest that lower body mass and lower body height can be key factors in lead climbing performance.

1 November 2019 in Nowa Audiofonologia
Verified
Journal Article
Open access
MZMonika Zaborek
Monika Zaborek
JŁJakub Łyczba
Jakub Łyczba
JRJoanna J. Rajchel
Joanna J. Rajchel
Piotr H. SkarzynskiPiotr H. Skarzynski
Piotr H. Skarzynski
Zespół Fahra jest rzadką chorobą charakteryzującą się symetrycznymi zwapnieniami w obrębie jąder podstawy oraz w innych obszarach mózgu, zwłaszcza w okolicach wzgórza, jądra zębatego, móżdżku oraz hipokampa. W artykule przedstawiono zróżnicowaną symptomatologię zespołu na...